Alexandra Kropotova Sab Biotherapeutics, Inc. (SABS) insider trading activity

Alexandra Kropotova is CHIEF MEDICAL OFFICER of SAB Biotherapeutics, Inc.. Currently has a direct ownership of 44,284 shares of SABS, which is worth approximately $143,037. The most recent transaction as insider was on Dec 11, 2025, when has been sold 988 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 44.3K

2.18% 3M change

8.56% 12M change

Total Value Held $143,037

Alexandra Kropotova Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 11 2025	SELL Payment of exercise price or tax liability	-	988 Reduced 2.18%	44,284 Common Stock
Sep 19 2025	SELL Payment of exercise price or tax liability	-	1,977 Reduced 4.18%	45,272 Common Stock
Mar 27 2025	SELL Payment of exercise price or tax liability	-	1,179 Reduced 2.43%	47,249 Common Stock
Dec 18 2024	SELL Payment of exercise price or tax liability	-	9,072 Reduced 15.78%	48,428 Common Stock
Mar 14 2023	BUY Grant, award, or other acquisition	-	275,000 Added 50.0%	275,000 Common Stock
Jun 06 2022	BUY Grant, award, or other acquisition	-	300,000 Added 50.0%	300,000 Common Stock

Also insider at

IBIO

iBio, Inc. Healthcare

Director